Average Co-Inventor Count = 6.03
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The United States of America, as Represented by the Secretary, Department of Health and Human Services (8 from 3,540 patents)
2. University of Rochester (4 from 975 patents)
3. The University of Arizona (4 from 975 patents)
4. University of Nebraska (4 from 937 patents)
5. University of London (4 from 89 patents)
6. British Columbia Cancer Agency Branch (4 from 65 patents)
7. Universität De Barcelona (4 from 47 patents)
8. Oslo University Hospital Hf (4 from 11 patents)
9. Hospital Clinic De Barcelona (3 from 21 patents)
10. Julius-Maximilians-University of Wurzburg (3 from 6 patents)
11. Oregon Health & Science University (2 from 509 patents)
12. Fundacio Clinic (2 from 2 patents)
13. The United States of America as Represented by the Department of Health (1 from 1,217 patents)
14. Hospital Clinic (1 from 1 patent)
15. Julius-Maximilians-University of Wuerzburg (1 from 1 patent)
9 patents:
1. 11028444 - Survival predictor for diffuse large B cell lymphoma
2. 10697975 - Methods for identifying, diagnosing, and predicting survival of lymphomas
3. 9970059 - Survival predictor for diffuse large B cell lymphoma
4. 8748114 - ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
5. 8131475 - Methods for identifying, diagnosing, and predicting survival of lymphomas
6. 7981610 - ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
7. RE40839 - Taxol treatment of cancer
8. 7329502 - ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
9. 5496846 - Taxol treatment of breast cancer